Strengthening Families & Communities LLC Sells 3,773 Shares of Danaher Co. (NYSE:DHR)

Strengthening Families & Communities LLC reduced its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 96.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 140 shares of the conglomerate's stock after selling 3,773 shares during the period. Strengthening Families & Communities LLC's holdings in Danaher were worth $32,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. First Fiduciary Investment Counsel Inc. raised its holdings in Danaher by 1.8% during the fourth quarter. First Fiduciary Investment Counsel Inc. now owns 42,796 shares of the conglomerate's stock valued at $9,824,000 after buying an additional 741 shares in the last quarter. Pineridge Advisors LLC raised its holdings in Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after buying an additional 57 shares in the last quarter. Quilter Plc raised its holdings in Danaher by 4.6% during the fourth quarter. Quilter Plc now owns 62,371 shares of the conglomerate's stock valued at $14,317,000 after buying an additional 2,746 shares in the last quarter. Elevate Capital Advisors LLC bought a new position in Danaher during the fourth quarter valued at about $829,000. Finally, Angeles Wealth Management LLC raised its holdings in Danaher by 5.1% during the fourth quarter. Angeles Wealth Management LLC now owns 4,229 shares of the conglomerate's stock valued at $971,000 after buying an additional 204 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Remove Ads

Insider Activity

In other news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 11.10% of the stock is currently owned by corporate insiders.

Danaher Price Performance

DHR traded up $3.07 during midday trading on Friday, reaching $206.66. 4,791,695 shares of the company's stock were exchanged, compared to its average volume of 4,481,736. The firm has a market capitalization of $149.26 billion, a price-to-earnings ratio of 39.14, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a one year low of $196.80 and a one year high of $281.70. The business has a 50-day simple moving average of $230.00 and a two-hundred day simple moving average of $249.96.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts' consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the business earned $2.09 earnings per share. As a group, research analysts predict that Danaher Co. will post 7.67 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.52%. The ex-dividend date of this dividend was Friday, December 27th. Danaher's dividend payout ratio (DPR) is currently 20.45%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. StockNews.com downgraded Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, December 14th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $277.00 price target (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. UBS Group lowered their price target on Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a research report on Wednesday, October 23rd. Barclays lowered their price target on Danaher from $275.00 to $240.00 and set an "equal weight" rating on the stock in a research report on Thursday, January 30th. Finally, Scotiabank assumed coverage on Danaher in a research report on Monday, December 23rd. They issued a "sector perform" rating and a $265.00 price target on the stock. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and an average price target of $278.00.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.